Chargement en cours...
STINGing the Tumor's immune evasion mechanism
In order to enhance the STING dependent type I interferon (IFN) response, we formulated cyclic dinucleotides (CDN) with cancer vaccines to develop STINGVAX. Interestingly, tumors from STINGVAX treated mice demonstrated dramatic PD-L1 upregulation. When combined with PD-1 blockade, STINGVAX induced r...
Enregistré dans:
| Publié dans: | Oncoimmunology |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5889205/ https://ncbi.nlm.nih.gov/pubmed/29632707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1083673 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|